{"text": ["10", "Companies", "Making", "Huge", "Stock", "Buybacks", "in", "2018"], "created_at": "2018-03-06 21:13:48"}
{"text": ["10", "Companies", "Making", "Huge", "Stock", "Buybacks", "in", "2018"], "created_at": "2018-03-06 21:13:48"}
{"text": ["Profit", "From", "Share", "Buyback", "Boom", "With", "These", "ETFs"], "created_at": "2018-03-06 18:15:04"}
{"text": ["Profit", "From", "Share", "Buyback", "Boom", "With", "These", "ETFs"], "created_at": "2018-03-06 18:15:04"}
{"text": ["Gilead", "Sciences\u2019", "Valuation", "in", "March", "2018"], "created_at": "2018-03-06 17:23:55"}
{"text": ["Bristol-Myers", "Squibb\u2019s", "Eliquis", "and", "Orencia", "Saw", "Solid", "Growth", "in", "2017"], "created_at": "2018-03-06 16:15:13"}
{"text": ["Gilead", "Announces", "Positive", "Data", "on", "New", "HIV", "Therapy", "Biktarvy"], "created_at": "2018-03-06 15:21:09"}
{"text": ["Gilead", "Announces", "Positive", "Data", "on", "New", "HIV", "Therapy", "Biktarvy"], "created_at": "2018-03-06 15:21:09"}
